Should New Entrants Bother With Selling Point Solutions To Employers?
Employers are struggling with point solution fatigue, but does that mean new startups shouldn't be selling to them anymore? Experts have mixed opinions.
Employers are struggling with point solution fatigue, but does that mean new startups shouldn't be selling to them anymore? Experts have mixed opinions.
The voluntary removal of ALS drug Relyvrio from the market comes with a corporate restructuring that turns Amylyx Pharmaceuticals’ focus to other neurodegenerative diseases. But the company also has another ALS drug candidate set to begin clinical testing this year.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Implementing diverse and sustained strategies to empower frontline workers should be the cornerstone of any modern healthcare workforce management program.
The MedCity INVEST conference is scheduled for May 21-22 at the Ritz Carlton hotel in Chicago. In addition to panel discussions around some of the hottest topics in healthcare transformation, there is also a startup pitch contest, a presentation on government funding for startups and networking opportunities.
In a new era of cost-conscientiousness in MA, supplemental benefits will be assessed on their usefulness — to both payers and beneficiaries
In a letter, several stakeholders urged the Drug Enforcement Administration to release a revised proposed rule on the virtual prescribing of controlled substances. This comes as Covid-19 flexibilities that allow controlled substances to be prescribed via telehealth without an in-person exam are set to expire at the end of the year.
This week, Eko Health received FDA clearance for a new AI-powered tool that aids in the early detection of low ejection fraction, a key indicator of heart failure. The tool, which was developed in collaboration with Mayo Clinic, is embedded into Eko’s digital stethoscopes.
America’s Health Insurance Plans, the Better Medicare Alliance and the Association for Community Affiliated Plans all came out against CMS’ final 2025 Medicare Advantage and Part D rate announcement.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
There are some lingering misconceptions around the use of VR that are likely to give instructors pause when considering whether to add a VR component to the nursing curriculum. This article addresses five common misconceptions about immersive VR simulations.
Do you advise self-insured employers? Your insights will offer leading, innovative points of view that can guide employers and peers. Join us for this year's survey!
Certain features, commonplace on most e-commerce platforms, can help transform clinical trial search databases.
The modern healthcare environment will require ambidextrous experts in healthcare and AI
Approval of Akebia Therapeutics’ Vafseo is based on additional post-marketing safety data from Japan, where the drug has been used since 2020. The FDA rejected the drug two years ago due to concerns about cardiovascular safety.